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Editorial
Patterns of disease in American children have changed dramatically
in the past 200 years. Acquired immunodeficiency syndrome
(AIDS), severe acute respiratory syndrome (SARS), and tuberculosis
notwithstanding, vaccines, antibiotics, and improved hygiene have
controlled the classic infectious diseases. Infant mortality has
decreased by 90%. Life expectancy has nearly doubled. 
Yet amid this success a new challenge has arisen. Chronic diseases
have increased sharply in incidence and have become the leading
causes of childhood illness: 
• Asthma incidence and mortality have more than doubled [Centers for Disease
Control and Prevention (CDC) 1995a, 1995b]. 
• Despite declining mortality, incidence of acute lymphocytic leukemia increased
by 61.7% from 1973 to 1999 (Robison et al. 1995).
• Incidence of primary brain cancer increased by 39.6% from 1973 to 1994
(Schechter 1999).
• Birth defects of the male reproductive system, such as hypospadias, doubled in
frequency from 1970 to 1993 (Paulozzi et al. 1997). 
• Neurodevelopmental disorders—including learning disabilities, dyslexia, men-
tal retardation, attention deficit disorder, and autism—are highly prevalent
and affect 5–10% of the 4 million babies born in the United States each year
(Bertrand et al. 2001; CDC 2004a, 2004b; LeFever et al. 1999; Safer et al.
1996; Zito et al. 2000).
• Prevalence of childhood obesity has trebled (Galvez et al. 2003).
• Incidence rates of chronic neurodegenerative diseases of late life such as Parkinson
disease and dementia and of certain cancers have increased markedly, raising the
possibility of early-life antecedents (Cory-Slechta et al., unpublished data).
Although much remains to be learned about the causes of these
trends, evidence is accumulating that environmental factors make
important contributions.
• Airborne fine particulates have been shown to cause asthma and to trigger asth-
matic atttacks (Salam et al. 2004).
• Ozone, oxides of nitrogen, environmental tobacco smoke, and indoor air pollu-
tants all are now recognized triggers for asthma (Suh et al. 2000; Wallace et al.
2003).
• Childhood cancer has long been linked to ionizing radiation. More recently,
benzene, 1,3-butadiene, and pesticides have been etiologically associated
(Daniels et al. 2001; Lee et al. 2004).
• Neurobehavioral impairment has been observed following exposure of the fetal
brain to even low levels of lead (Baghurst et al. 1987; Canfield et al. 2003;
Dietrich et al. 1987; Lanphear et al. 2000; Opler et al. 2004; Wasserman et al.
2000), methyl mercury (Grandjean et al. 1997, 2004; Kjellstrom et al. 1986,
1989; Murata et al. 2004; National Research Council 2000), pesticides
(Berkowitz et al. 2004; Perera et al. 2003), polychlorinated biphenyls (Jacobson
and Jacobson 1996), and ethanol (Lupton et al. 2004). A recent National
Academy of Sciences study (2000) suggests that at least 28% of developmental
disabilities in children are caused by environmental factors acting alone or in
concert with genetic susceptibility. 
Until now, progress in elucidating the role of the environment in chronic
childhood disease has been slow and incremental. Nearly all studies have
examined relatively small populations of children; have considered only one
chemical toxicant at a time; have had little statistical power to examine inter-
actions among chemical, social, and behavioral factors in the environment;
have had limited ability to examine gene–environment interactions (Olden
2004); and have suffered from brief duration of follow-up. Also, many previ-
ous studies have been retrospective in design and thus have been forced to
estimate past exposures from limited and sometimes biased historical data.
To overcome these difficulties, the President’s Task Force on Environ-
mental Health and Safety Risks to Children recommended in 1998 (U.S.
Department of Health and Human Services 2004) that a large prospective
epidemiologic study of American children be undertaken. In response, the
U.S. Congress through
the Children’s Health
Act of 2000 authorized
the National Institute
of Child Health and
Human Development
(NICHD) “to conduct a national longitudinal study of environmental
influences (including physical, chemical, biological and psychosocial) on
children’s health and development” (Children’s Health Act 2000). The
National Institute of Environmental Health Sciences (NIEHS), the CDC,
and the U.S. Environmental Protection Agency (EPA) join the NICHD
in planning and conducting this study.
Key features of this far-reaching study—now termed the National
Children’s Study (NCS)—are that it will follow a representative sample
of 100,000 American children from early pregnancy through age 21; a
subset maybe recruited before conception. Exposure histories and bio-
logic samples will be obtained during pregnancy and from children as
they grow, obviating the need for retrospective assessments of expo-
sures. The large sample size will facilitate simultaneous examination of
the effects of multiple chemical exposures, of interactions among
them, and of interactions among biologic, chemical, behavioral, and
social factors. Each child will be screened genetically, thus permitting
study of gene–environment interactions. Follow-up will extend over
decades. For the past four years, working groups convened by
NICHD have been developing the NCS: formulating core hypothe-
ses, delineating research protocols, and planning logistics. The study is
now ready for the field.
Previous major prospective epidemiologic studies have yielded
invaluable gains in knowledge of disease causation and have provided
critical tools for prevention and treatment. The Framingham Heart
Study (Framingham, MA), for example, was established in 1948 at a
time when heart disease and stroke were epidemic in the United
States. The goal was to identify preventable risk factors. Within a few
years, data from Framingham identified cigarette smoking (Dawber
1960) and elevated cholesterol and hypertension as preventable causes
of cardiovascular disease (CVD) (Kannel et al. 1961, 1978); later
analyses elucidated the role of elevated triglycerides, sedentary lifestyle,
and diabetes. This information provided the blueprint for the major
reductions in incidence of CVD that we have achieved in the United
States over the past four decades (CDC 1999). 
We anticipate that the NCS will yield equally enormous societal
benefits. Six of the chronic diseases that the study plans to examine
—obesity, injury, asthma, diabetes, schizophrenia, and autism—cost
America $642 billion per year (Bromet and Fennig 1999; CDC
2004a, 2004b, 2004c, 2004d, 2004e, 2004f, 2004g; National
Alliance for Autism Research 2002; U.S. Department of Health and
Human Services 2001; Weiss 2001; Yeargin-Allsop et al. 2002). If
the NCS were to produce a reduction of only 1% in incidence of
these diseases, the annual savings would amount to $6.4 billion, far
more than the $2.7 billion price tag of the study over 25 years.
Despite the enormous potential of the NCS, its funding is in criti-
cal jeopardy. In each of the past 4 years, the annual budget has been
$12 million, a sum provided by contributions from the NICHD, the
NIEHS, the CDC, and the U.S. EPA. But now to move the study for-
ward, there is need in 2005 to establish a data-coordinating center, a
repository for secure storage of biologic samples, and a series of region-
ally distributed vanguard recruitment sites. For these tasks, NICHD
needs $15 million in new dollars above their regular budget. Without
at least $27 million in federal funding in 2005, NICHD will likely be
forced to cancel or at least postpone the study. 
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The NCS has benefited from strong and bipartisan leadership in
Congress and from the support of a broad-based coalition that includes
the American Academy of Pediatrics, the U.S. Conference of Catholic
Bishops, the American Chemistry Council, the Learning Disabilities
Association, and the March of Dimes. But still it is in dire fiscal peril.
The NCS represents an extraordinary opportunity. If the study
receives the funding that it needs in 2005, it will begin as early as
2009 to produce data that will save children’s lives and improve their
health. The NCS is a national investment in the future that for the
sake of our children we must make today.
Leonardo Trasande
Center for Children’s Health and the Environment, Department of
Community and Preventive Medicine, New York, NY
E-mail: leo.trasande@mssm.edu
Philip J. Landrigan
Center for Children’s Health and the Environment, Department of
Community and Preventive Medicine, New York, NY
E-mail: phil.landrigan@mssm.edu
Leonardo Trasande is assistant director of the Center for Children's
Health and the Environment, and an instructor in Community and
Preventive Medicine and in Pediatrics at the Mount Sinai School of
Medicine. He also holds a lectureship in Pediatrics at Harvard Medical
School.
Philip J. Landrigan is the Ethel H. Wise Professor and chair of the
Department of Community and Preventive Medicine, and director of
the Center for Children's Health and the Environment at the Mount
Sinai School of Medicine.
REFERENCES
Baghurst PA, Robertson EF, McMichael AJ, Vimpani GV, Wigg NR, Roberts RR. 1987. The Port
Pirie Cohort Study: lead effects on pregnancy outcome and early childhood development.
Neurotoxicology 8(3):395–401.
Berkowitz GS, Wetmur JG, Birman-Deych E, Obel J, Lapinski, RH, Godbold JH, et al. 2004. In
utero pesticide exposure, maternal paraoxonase activity, and head circumference. Environ
Health Perspect 112:388–391. 
Bertrand J, Mars A, Boyle C, Bove F, Yeargin-Allsopp M, Decoufle P. 2001. Prevalence of autism
in a United States population: the Brick Township, New Jersey, investigation. Pediatrics
108(5):1155–1161.
Bromet EJ, Fennig S. 1999. Epidemiology and natural history of schizophrenia. Biol Psychiatry
46(7):871–881.
Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. 2003.
Intellectual impairment in children with blood lead concentrations below 10 microg per
deciliter. N Engl J Med 348(16):1517–1526.
CDC. 1995a. Children at risk from ozone air pollution, 1991–1993. MMWR Morb Mortal Wkly Rep
44:309–312. 
CDC. 1995b. Asthma—United States, 1982–1992. MMWR Morb Mortal Wkly Rep 43:952–955.
CDC. 1999. Achievements in public health, 1900–1999: decline in deaths from heart disease and
stroke—United States, 1900–1999. MMWR Morb Mortal Wkly Rep 48(30):649–656.
CDC. 2004a. Developmental Disabilities. Available: http://www.cdc.gov/ncbddd/dd/default.htm
[Accessed 21 June 2004].
CDC. 2004b. Economic costs associated with mental retardation, cerebral palsy, hearing loss,
and vision impairment—United States 2003. MMWR Morb Mortal Wkly Rep 53(03):57–59.
CDC. 2004c. National Asthma Control Program. Available: http://www.cdc.gov/nceh/airpollu-
tion/asthma/asthmaAAG.htm [Accessed 30 August 2004].
CDC. 2004d. National Diabetes Fact Sheet: General Information and National Estimates on
Diabetes in the United States. Available: http://www.cdc.gov/diabetes/pubs/factsheet.htm
[Accessed 30 August 2004].
CDC. 2004e. National Center for Injury Prevention and Control. Injuries among Children and
Adolescents. Available: http://www.cdc.gov/ncipc/factsheets/children.htm [Accessed 30
August 2004].
CDC. 2004f. Cost of Injury in the United States: A Report to Congress. Available:
http://www.cdc.gov/ncipc/pub-res/cost_of_injury/ch2-3.pdf [Accessed 13 September
2004].
CDC. 2004g. National Center for Health Statistics. Asthma Prevalence, Health Care Use and
Mortality, 2000–2001. Available: http://www.cdc.gov/nchs/products/pubs/pubd/
hestats/asthma/asthma.htm [Accessed 30 August 2004].
Children’s Health Act of 2000. 2000. Public Law 106-310.
Daniels JL, Olshan AF, Teschke K, Hertz-Picciotto I, Savitz DA, Blatt J, et al. 2001. Residential
pesticide exposure and neuroblastoma. Epidemiology 12(1):20–27.
Dawber TR. 1960. Summary of recent literature regarding cigarette smoking and coronary heart
disease. Circulation 22:164–66.
Dietrich KN, Krafft KM, Bornschein RL, Hammond PB, Berger O, Succop PA, et al. 1987. Low-
level fetal lead exposure effect on neurobehavioral development in early infancy.
Pediatrics 80(5):721–730.
Grandjean P, Murata K, Budtz-Jorgensen E, Weihe P. 2004. Cardiac autonomic activity in
methylmercury neurotoxicity: 14-year follow-up of a Faroese birth cohort. J Pediatr
144(2):169–176.
Grandjean P, Weihe P, White RF, Debes F, Araki S, Yokoyama K, 1997. Cognitive deficit in 7-year-
old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 19(6):417–428.
Galvez MP, Frieden TR, Landrigan PJ. 2003. Obesity in the 21st century. Environ Health Perspect
111:A684–A685. 
Jacobson JL, Jacobson SW. 1996. Intellectual impairment in children exposed to polychlori-
nated biphenyls in utero. N Engl J Med 335:783–789.
Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes JI. 1961. Factors of risk in the develop-
ment of coronary heart disease—six year follow-up experience; the Framingham Study.
Ann Intern Med 55:33–50.
Kannel WB, Wolf PA, Dawber TR. 1978. Hypertension and cardiac impairments increase stroke
risk. Geriatrics 33:71–83.
Kjellstrom T, Kennedy P, Wallis S, Mantell C. 1986. Physical and Mental Development of
Children With Prenatal Exposure to Mercury From Fish. Stage I: Preliminary Tests at Age 4.
Report 3080. Solna, Sweden:National Swedish Environmental Protection Board. 
Kjellstrom T, Kennedy P, Wallis S, Stewart A, Friberg L, Lind B, et al. 1989. Physical and Mental
Development of Children With Prenatal Exposure to Mercury From Fish. Stage II: Interviews
and Psychological Tests at Age 6. Report 3642. Solna, Sweden:National Swedish
Environmental Protection Board.
Lanphear BP, Dietrich K, Auinger P, Cox C. 2000. Cognitive deficits associated with blood lead
concentrations < 10 microg/dL in US children and adolescents. Public Health Rep
115(6):521–529.
Lee WJ, Cantor KP, Berzofsky JA, Zahm SH, Blair A. 2004. Non-Hodgkin’s lymphoma among
asthmatics exposed to pesticides. Int J Cancer 111(2):298–302.
LeFever GB, Dawson KV, Morrow AL. 1999. The extent of drug therapy for attention deficit-
hyperactivity disorder among children in public schools. Am J Public Health 89:1359–1364.
Lupton C, Burd L, Harwood R. 2004. Cost of fetal alcohol spectrum disorders. Am J Med Genet
127C(1):42–50.
Murata K, Weihe P, Budtz-Jorgensen E, Jorgensen PJ, Grandjean P. 2004. Delayed brainstem
auditory evoked potential latencies in 14-year-old children exposed to methylmercury. J
Pediatr 144(2):177–183.
National Academy of Sciences, Committee on Developmental Toxicology. 2000. Scientific
Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC:National
Academies Press.
National Alliance for Autism Research. 2002. What is Autism? Available:
http://www.naar.org/aboutaut/whatis.htm [Accessed 30 August 2004].
National Research Council. 2000. Toxicological Effects of Methylmercury. Washington, DC:
National Academies Press. 
Olden K. 2004. Genomics in environmental health research—opportunities and challenges.
Toxicology 198(1–3):19–24.
Opler MG, Brown AS, Graziano J, Desai M, Zheng W, Schaefer C, et al. 2004. Prenatal lead
exposure, δ-aminolevulinic acid, and schizophrenia. Environ Health Perspect 112:548–552.
Paulozzi LJ, Erickson JD, Jackson RJ. 1997. Hypospadias trends in two US surveillance systems.
Pediatrics 100(5):831–834.
Perera FP, Rauh V, Tsai WY, Kinney P, Camann D, Barr D, et al. 2003. Effects of transplacental
exposure to environmental pollutants on birth outcomes in a multiethnic population.
Environ Health Perspect 111:201–206. 
Robison LL, Buckley JD, Bunin G. 1995. Assessment of environmental and genetic factors in the
etiology of childhood cancers: the Childrens Cancer Group epidemiology program. Environ
Health Perspect 103(suppl 6):111–116.
Safer DJ, Zito JM, Fine EM. 1996. Increased methylphenidate usage for attention deficit disorder
in the 1990s. Pediatrics 98:1084–1088.
Salam MT, Li YF, Langholz B, Gilliland FD, Children’s Health Study. 2004. Early-life environmental
risk factors for asthma: findings from the Children’s Health Study. Lancet 363(9403):119–125. 
Schechter CB. 1999. Re: Brain and other central nervous system cancers: recent trends in inci-
dence and mortality. J Natl Cancer Inst 91:2050–2051.
Suh HH, Bahadori T, Vallarino J, Spengler JD. 2000. Criteria air pollutants and toxic air pollu-
tants. Environ Health Perspect 108(suppl 4):625–633.
U.S. Department of Health and Human Services. The President's Task Force on Environmental
Health Risks and Safety Risks to Children. Available:
http://nationalchildrensstudy.gov/about/task_force.cfm [Accessed 13 September 2004].
U.S. Department of Health and Human Services. Public Health Service, Office of the Surgeon
General. 2001. The Surgeon General’s Call to Action to Prevent and Decrease Overweight
and Obesity. Available: http://www.surgeongeneral.gov/topics/obesity/calltoaction/
CalltoAction.pdf [Accessed 30 August 2004].
Wallace LA, Mitchell H, O’Connor GT, Neas L, Lippmann M, Kattan M, et al. 2003. Particle con-
centrations in inner-city homes of children with asthma: the effect of smoking, cooking, and
outdoor pollution. Environ Health Perspect 111:1265–1272.
Wasserman GA, Liu X, Popovac D, Factor-Litvak P, Kline J, Waternaux C, et al. 2000. The
Yugoslavia Prospective Lead Study: contributions of prenatal and postnatal lead exposure
to early intelligence. Neurotoxicol Teratol 22(6):811–818.
Weiss KB, Sullivan SD. 2001. The health economics of asthma and rhinitis. I. Assessing the eco-
nomic impact. J Allergy Clin Immunol 107:3–8.
Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Schendel D. 2002. Prevalance
of autism in a US metropolitan city. JAMA 289(1):49–55.
Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F. 2000. Trends in the prescribing of
psychotropic medications to preschoolers. JAMA 283:1025–1030.
A 790 VOLUME 112 | NUMBER 14 | October 2004 • Environmental Health Perspectives